EWA
VBIV

EverSource Wealth Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

EverSource Wealth Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-212
Closed -$697 – 2686
2023
Q2 		$697 Buy
+212
New +$641 ﹤0.01% 2293

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

EverSource Wealth Advisors's VBIV Position: Q3 2023 in Review

EverSource Wealth Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2023, closing a stake of 212 shares — an estimated $697 sold.

EverSource Wealth Advisors first reported a position in VBIV in Q2 2023 and held it in 1 quarter. The position peaked at $697 in Q2 2023. 37 funds tracked by Wall St. Rank hold VBIV as of Q3 2023.

  • EverSource Wealth Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2023 after selling out during the quarter.
  • EverSource Wealth Advisors sold 212 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2023, an estimated $697.
  • EverSource Wealth Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2023 and held it in 1 quarter.
  • EverSource Wealth Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $697 in Q2 2023.
  • 37 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2023.

Based on EverSource Wealth Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.